Valeant continues Russian spending spree with $180m Natur Produkt buy
This article was originally published in Scrip
Executive Summary
Valeant Pharmaceuticals International Inc. saw its stock price tick up slightly after announcing its $180 million purchase of Russian over-the-counter cold remedy company Natur Produkt.